We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Medica 2024 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Activation of Channel Proteins Slows Cancer Cell Growth and Impairs Metastatic Capability

By LabMedica International staff writers
Posted on 04 Jan 2017
A team of German researchers working with an aggressive breast cancer cell line showed that activation of TRPV1, a transient receptor potential channels protein, caused significant inhibition of cancer cell growth and induced apoptosis and necrosis.

Transient receptor potential (TRP) channels contribute to the regulation of intracellular calcium, which can promote cancer growth in cases of dysregulation of gene transcription and calcium-dependent pro-proliferative or anti-apoptotic mechanisms. Several studies have begun to elucidate the roles of TRPV1, TRPV6, TRPM8, and TRPC1 in cancer progression; however, no study has examined the expression profiles of human TRP channels in breast cancer on a large scale.

Image: A homology model of the TRPV1 calcium ion channel (Photo courtesy of Wikimedia Commons).
Image: A homology model of the TRPV1 calcium ion channel (Photo courtesy of Wikimedia Commons).

In the current study, investigators at Ruhr-Universität Bochum (Germany) worked with the SUM149PT cell culture model system for aggressive triple-negative breast cancer. The investigators activated the cells' TRPV1 receptors by exposing the cell cultures for several hours or days to the compound capsaicin - an active ingredient of pungent substances such as chili peppers - or to helional - a chemical compound used as a perfume in soap and laundry detergent.

Results published in the December 13, 2016, issue of the journal Breast Cancer - Targets and Therapy revealed that activation of the TRPV1 receptor in the cell cultures by capsaicin or helional caused the cancer cells to divide more slowly and to die in increasingly larger numbers. The surviving cells showed decreased motility, which implied that their ability to form metastases was impaired.

"If we could switch on the TRPV1 receptor with specific drugs, this might constitute a new treatment approach for this type of cancer," said senior author Dr. Hanns Hat, professor of cell physiology at Ruhr-Universität Bochum. "An intake via food or inhalation is insufficient for this purpose."

Related Links:
Ruhr-Universität Bochum


New
Gold Member
C-Reactive Protein Reagent
CRP Ultra Wide Range Reagent Kit
Automated Blood Typing System
IH-500 NEXT
New
17 Beta-Estradiol Assay
17 Beta-Estradiol Assay
New
FLU/RSV Test
Humasis FLU/RSV Combo

Latest BioResearch News

Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns

Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma

New Method Simplifies Preparation of Tumor Genomic DNA Libraries